Form 4: Tandem Diabetes Care Director Dick Allen Reports Stock Transactions

Director Dick Allen reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Summary

• On May 24, 2024, Director Dick Allen reported transactions involving Tandem Diabetes Care Inc. stock.
• Allen acquired 4,434 shares of common stock through the exercise of restricted stock units at a price of $51.73 per share.
• Allen also reported holding 21,892 shares indirectly through the Allen Family Trust, 5,000 shares through Allen Cornerstone Ventures L.P., and 1,000 shares through the Gammon Children's 2000 Trust FBO Jake Allen Gammon.
• On May 22, 2024, Allen was awarded 4,387 restricted stock units (RSUs) which will vest on the one-year anniversary of the grant date.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units awarded on May 22, 2024, will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Long-Term Incentive Plan.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare and medical device industry.

Comparison to Industry Standards

• Insider transactions are regularly monitored in the medical device industry, with companies like Medtronic and Abbott also seeing frequent filings by their executives and directors.
• The size and frequency of these transactions are typical for directors in publicly traded companies.

Stakeholder Impact

• The transactions may influence investor perception of the company, but the direct impact is likely minimal.

Key Dates